Skip to content
  • About
    • Expert Index
    • Editorial Board
    • Editorial Team
    • Editorial Policy
  • Contact
  • Sign up

Visit

vjdementia
VJNeurology
Logo
  • Home (current)
  • Diseases
    Parkinson's Disease
    Multiple Sclerosis and Related Disorders
    Headache
    Amyotrophic Lateral Sclerosis
    Epilepsy
    Sleep Disorders
    View all Diseases
  • Topics
    Diagnostics
    Biology
    Trial Updates
    Treatment
    Surgery
    Prevention
    View all Topics
  • Conferences
    ACTRIMS Forum 2021
    CONy 2020
    MDS 2020
    AAIC 2020
    FENS 2020
    EAN 2020
    View all Conferences
  • Features
    • About
      • Expert Index
      • Editorial Board
      • Editorial Team
      • Editorial Policy
    • Contact
    • Sign up

Prevention

Using AI to predict epileptic seizures 2:45
Using AI to predict epileptic seizures
Daniel Goldenholz • 26 Oct 2020
MS: challenges and the impact of a healthy lifestyle 2:16
MS: challenges and the impact of a healthy lifestyle
Abhijit Chaudhuri • 21 Oct 2020
Gene-environment interactions in Huntington’s disease 3:34
Gene-environment interactions in Huntington’s disease
Anthony Hannan • 20 Jul 2020
Gene-environment interactions and neurodegeneration 1:48
Gene-environment interactions and neurodegeneration
Tara Spires-Jones • 16 Jul 2020
Therapeutic landscape for cluster headache 11:31
Therapeutic landscape for cluster headache
Stewart Tepper • 24 May 2020
Challenges in migraine management 2:09
Challenges in migraine management
Uwe Reuter • 22 May 2020
CGRP monoclonal antibodies & migraine management during COVID-19 pandemic 20:54
CGRP monoclonal antibodies & migraine management during COVID-19 pandemic
Stewart Tepper • 24 May 2020
Benefit of migraine prevention with erenumab 19:11
Benefit of migraine prevention with erenumab
Stewart Tepper • 24 May 2020
The evolving landscape of migraine treatment and prevention 3:42
The evolving landscape of migraine treatment and prevention
Uwe Reuter • 22 May 2020
PROMISE-1: eptinezumab in episodic migraine 2:44
PROMISE-1: eptinezumab in episodic migraine
Messoud Ashina • 29 May 2020
Fremanezumab in patients with chronic or episodic migraine 2:52
Fremanezumab in patients with chronic or episodic migraine
Uwe Reuter • 22 May 2020
HER-MES study: erenumab versus topiramate in episodic migraine 2:30
HER-MES study: erenumab versus topiramate in episodic migraine
Uwe Reuter • 22 May 2020
Migraine: CGRP mAbs efficacy measured over time 1:30
Migraine: CGRP mAbs efficacy measured over time
Dagny Holle-Lee • 20 May 2020
The evolving migraine prevention landscape: EAN 2020 highlights 3:29
The evolving migraine prevention landscape: EAN 2020 highlights
Messoud Ashina • 29 May 2020
LIBERTY trial: erenumab in episodic migraine patients with prior preventive treatment failures 2:33
LIBERTY trial: erenumab in episodic migraine patients with prior preventive treatment failures
Uwe Reuter • 22 May 2020
PEARL study: fremanezumab for chronic or episodic migraine in the real world 3:16
PEARL study: fremanezumab for chronic or episodic migraine in the real world
Messoud Ashina • 29 May 2020
  • 1
  • 2
  • Next
Journal Pages
  • Diseases
  • Topics
  • Medicines
  • Trials
  • Conferences
  • Features
Newsletter

Receive the latest news and videos from VJNeurology via email

Sign up
Contact Us

Contact us for more information

mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJNeurology logo
The content of VJNeurology is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy